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1. Introduction  
Surgical aortic valve replacement has been proven to be the ultimate 
treatment of symptomatic aortic valve disease with low operative morbidity 
and mortality in selected patient groups [1]. Traditional surgical approaches 
require a midline sternotomy and cardiopulmonary bypass with or without 
cardioplegic arrest. To minimize the invasiveness of operations, a broad 
spectrum of techniques, including endoscopic and robotic surgery, has been 
developed and optimized [2, 3, 4]. 
Despite all the efforts to minimize the invasiveness of operations,  trauma 
associated with such surgical procedures still exist in a large number of 
patients such as general anesthesia, cosmetic scarring, and co-morbidities 
associated with ageing, age itself and repeat surgery as independent risk 
factors for an adverse outcome [2, 5, 6, 7]. All of these factors have led to 
develop an alternative to open heart operations, and recent reports [6, 8, 9, 
18, 23, 24, 25] indicated that percutaneous aortic valve implantation (PAVI) 
may become an effective and feasible procedure, which could benefit a large 
patient population. 
Percutaneous endovascular therapy has now become a reality. From early 
balloon valvulotomy for valvular stenosis [10, 11, 13, 14, 15], technologies 
have been developed to allow percutaneous replacement of pulmonary [23, 
32] and aortic valves [24, 25, 33], and repair of regurgitant mitral valves 
[12, 15, 16] in selected patients. 
Following extensive investigations in animals [17, 18, 19], early clinical 
reports [20, 21, 22, 23, 24, 25, 38] have shown successes in selected 
patients. As the criteria for patient selection, clinical safety and efficacy trials 
progressing, the role of these new technologies in patient care strategy will 
become better understood. 
Percutaneous aortic valve implantation is the development of a foldable 
heart valve that can be mounted on an expandable stent, delivered 
percutaneously through standard catheter-based techniques and implanted 
within a diseased aortic valve annulus [8,26,30], after the diseased valve 
has been dilated [25, 30], or resected [26, 27]. 
1.1. Historical perspective 
Percutaneous valve therapy was initially developed with aortic valve 
replacement. Such application can be traced back to nearly half a century 
ago. After Hufnagel and Harvey [28] surgically implanted the first valvular 
prosthesis in the descending aorta to prevent aortic regurgitation in 1951, 
Davies H. [29] in 1965 deployed a catheter-mounted unicuspid valve above 
the aortic valve for relief of the aortic regurgitation into the left ventricle; 
much effort has been made to develop percutaneous valved stent 
implantation since then.  
Andersen et al [30] initially described the percutaneous valve intervention in 
a swine model in 1992. These investigators fabricated a stent-mounted 
bioprosthetic valve and demonstrated that percutaneous implantation of 
expandable artificial aortic valves in the anesthetized closed-chest pigs by 
retrograde transluminal catheter technique is feasible. However, 
complication was associated with restriction of the coronary blood flow in 
subcoronary implantation. In the same year, Pavcnik [31] reported the 
implantation of an artificial caged-ball valve in dogs by percutaneous 
transcatheter approach. Although their results demonstrated that such 
procedure is feasible, a major difficulty as how to securely position this 
device in a dynamic environment was encountered, resulting in significant 
aortic regurgitation. 
Since then, several groups [17, 23, 25, 26] have made significant 
contributions to this development.  
1.2. Recent status 
Although the aortic valve replacement in symptomatic patients with aortic 
valve disease results in excellent symptom relief and long-term survival in 
most patients [1,2,4,5]. A growing number of patients are poor surgical 
(inoperable) candidates due to advanced age, co-morbidities and previous 
cardiac surgery. Based on our clinical experience, they represent a great 
management challenge [6, 7]. In the past decades, a number of minimally 
invasive techniques have been experimentally developed for the aortic valve 
replacement to overcome the difficulties [4, 17, 18, 19, 32]. 
Boudjemline and colleagues [9] reported their short term study in lambs in  
2002, they implanted a valve stent with trapping native leaflets between the 
outer nitinol stent and the inner platinum stent into the aortic annulus by 
retrograde approach. The restriction of coronary ostia, mitral valve 
insufficiency, and stent migration were encountered. 
In 1990s, Lutter and his group [18] began to perform the study of aortic 
valved stent implantation, and achieved success in animal studies in 2001. A 
percutaneous stent-based expandable valve was designed by mounting a 
fresh porcine aortic valve into a self-expandable nitinol stent by suture 
technique [26]. Although technical difficulties including visualization, 
deployment, stent migration, and rhythm disturbance were encountered in 
their studies, subsequent implantation of the valved stent was well tolerated, 
without significant valve insufficiency. This short term in vivo study provided 
significance that nonsurgical implantation of an aortic valve is feasible. 
Based on the contribution of these groups, PAVI have been developed, and 
experience is accumulating in humans. Bonhoeffer [32] first reported the 
use of a stent-mounted bioprosthesis for pulmonary valve implantation by a 
retrograde approach in 2000. This achievement clearly marked the 
beginning of the era of percutaneous valve replacement therapy in humans. 
Furthermore, the same group demonstrated the implantation of a biological 
valve stent into human pulmonary position by antegrade delivery approach, 
and reported the possibility of degeneration of the biological prosthesis [23]. 
Percutaneous aortic valve replacement with a stent-mounted bioprosthetic 
valve device was initially reported by Cribier et al in 2002 [24]. They 
published the first human percutaneous aortic valved stent implantation 
utilizing an antegrade transseptal approach within a stenotic aortic valve. In 
2004, by using an antegrade transseptal approach, the same group 
successfully implanted the valved stent into the stenotic aortic position in 
eleven end-stage patients without impairing the coronary flow or mitral 
valve function. Although a successful mid-term therapeutic result was 
achieved, a mild paravalvular aortic regurgitation was noticed. 
Although it is at its early stage with growing experience, all these 
preliminary studies suggest that percutaneous, and transapical valved stent 
implantation in the aortic position can be achieved in patients with 
end-stage calcific aortic stenosis and may become an important therapeutic 
option for inoperable patients [39]. 
Despite PAVI hold great promise, and has been proven to be feasible. On the 
other hand, many technological difficulties and limitations still exist. 
 
1.3. Limitations and Technical Difficulties  
Recently published case reports [24, 25] show the technical feasibility of 
remote access aortic valve implantation.  However, severe hindrances to 
aortic valve implantation remain in percutaneous approaches, including: 
optimal attachment of the valve into the stent, function preservation of the 
valved stent, functional anchoring mechanism, appropriate vessel access, 
suitable visualization method, and potential tools for removal of calcification 
and native valves [8, 26, 27, 30]. Furthermore, due to the difficulty 
positioning the stent into the calcified and stenotic aortic annulus, 
dislodgement and migration of the valved stent, potential complications 
unique to this procedure include a significant incidence of paravalvular 
leakage, calcific embolism, stroke, small aortic valve area, and acute heart 
failure [8, 24, 25, 31, 38].  
In the early stage of PAVI, some experimental percutaneous techniques, 
placing valved stent in sub- or supra-aortic position showed high 
complication rates, including the restriction of the coronary blood flow [30, 
31] for the infeasibility to implant the aortic valved stent into the aortic 
annulus. 
Lately, most investigators [8, 9, 26, 27, 33, 34, 46] reported the impairment 
of the coronary blood flow due to the position of the coronary orifice and the 
close relationship with the aortic leaflets, valved stent, and anterior mitral 
leaflet during the PAVI. Two potential risks for impaired coronary flow or 
even complete occlusion of the coronary orifice and consecutive fatal 
myocardial infarction were considered as: direct occlusion by parts of the 
valved stent, or obstruction by the native aortic leaflets folded upwards, and 
being compressed against the coronary ostia.   
Up to now, the interest in orthotopic PAVR states accumulating. 
Physiologically, it is certainly preferable to implant the new valve in the 
orthotopic aorta, over the native valve, even if it is more technically 
demanding [35, 36]. To perform a reliable replacement, in cases of severe 
aortic stenosis the diseased valve has to be predilated, and removed [26, 
27]. Quaden [37] firstly reported the endovascular resection of human 
aortic valves in situ. The study showed an AVIC (Aortic Valve Isolation 
Chamber) system with its advances and drawbacks. The avoidance of 
embolism and coronary flow impairment caused by the debris were also 
described in the study.  
In 2004, Huber [35] published the feasibility of an acute surgical suture less 
aortic valve implantation without compromising coronary flow of a properly 
placed and sized valved stent. Furthermore, he reported the surgical 
approach, with precise measure of the aortic valve region, especially the 
coronary sinus dimension, and the analysis of post-deployment coronary 
flow allows the valved stent implantation of adult size to have adequate 
function. Later on, the same group demonstrated the right coronary ostia 
occlusion during the supra-annularly valved stent deployment via a 
transapical approach in twelve pigs [39].    
Based on the close proximity of the coronary orifice to the aortic valve 
leaflets, the continuity of the mitral valve annulus and the aortic annulus 
makes PAVI a major challenge [8, 9, 35]. To avoid the impairment of the 
coronary flow and paravalvular leakage during an orthotopic PAVI, a basic 
research concerning the relation between the valved stent and the aortic root 
anatomic structures (including the coronary arterial ostia, aortic leaflets) is 
necessary. 
 
1.4. Coronary blood flow impairment and anatomic structures 
of the aortic root 
Adequate perfusion of the heart depends fundamentally on the right 
morphological conditions of the left and the right coronary arteries. These 
arteries have the peculiarity of being the only ones filled during the diastolic 
phase of cardiac rhythm. Some conditions, such as anatomic integrity of the 
aortic valve, absence of valvular malformations, and anatomic 
malformations of the coronary arteries result in a reduction in coronary 
blood flow to the myocardium [40, 41, 42, 43, 44, 45]. 
Based on the observation that the impairment of coronary blood flow 
encountered in PAVI, many investigators supposed that the malfunction of 
the aortic root structures was due to the valved stent implantation in aorta, 
particularly in orthotopic position. The stent in the native aortic position may 
affect the anatomical and physiological integrity of the aortic root, between 
the coronary ostia and aortic leaflets during cardiac cycle. These mechanical 
factors indicate that coronary flow can be blocked either directly from the 
implanted stent, or from the native aortic leaflets immobilized and pushed 
against the coronary orifices [8, 9, 26, 27, 31, 38]. In 2007, Flecher et al [46] 
reported that coronary ostia obstruction may occur after PAVR in an in vitro 
study. They considered the native leaflets as the main cause of right or left 
coronary obstruction.   
Currently, several studies have been performed to describe the anatomic 
structures of the aortic root including the coronary ostia and aortic leaflets. 
In most investigations [40,47,48,49,50], two coronary ostia, one left and 
one right, located in the two aortic sinuses closer to the pulmonary trunk 
were described, and the position of the coronary ostia in relation to the 
sinutubular junction (STJ) and inter-commissural line of aortic leaflets was 
studied. 
Turner [49] reported that from the functional point of view, the typical 
vertical positioning of the ostia, particularly when both coronary ostia were 
above the inter-commissural line, seems to confer functional advantages for 
coronary flow during ventricular systole, and would also prevent the 
obstruction of the ostia when the aortic valve was opened.  Cavalcanti et al 
[40] described that the left coronary ostium is more medially located in 
regard to the inter-commissural distance than the right coronary ostium, 
which is displaced to the right side. Furthermore, Muriago et al [50] added 
that the more central location of the left coronary ostium is appropriated and 
justified, because the left coronary artery heads to the space between the 
pulmonary trunk and the left auricle, branching right after its origin. They 
also demonstrated that the variations in the position of the coronary ostia in 
relation to the aortic leaflets and the diameter of the ostia may be involved 
in the possible reduction in coronary blood flow.  
In the current study we observed and measured these aortic root structures 
(including the aorta, the coronary ostia, and the aortic leaflets) on 40 fresh 
adult heart specimens. Through the post mortem aortic valved stent 
implantation, we investigated the relation of coronary ostia, aortic leaflets, 
and valved stent to find how the PAVI influence the coronary blood flow.   
2. Materials and Methods 
2.1. Materials 
Between March 2007 and August 2007, 40 post mortem hearts were 
enrolled and dissected in our study, collected at autopsy in the Department 
of Pathology of University Hospital of Schleswig-Holstein. All these autopsy 
material originated from the white adults of both genders (19 men, and 21 
women). Those patients died due to different reasons including cardiac 
surgery and cardiology disease, respiratory disease, trauma, advanced 
cancer, pulmonary embolism, hemorrhage or embolism of the brain, and 
so forth. The cadavers were kept in cool place until they were used for 
autopsy. The general characteristics of the patients at death were listed in 
table 2. 1.  
 
Tab.2. 1: Patients general characteristics (n=40, male 19; female 21). 
 N Minimum Maximum Mean Std. 
Deviation 
Age (years) 
Height (cm) 
Body Weight (Kg) 
Heart Weight (g) 
Body Mass Index 
(Kg/m2) 
40 
40 
40 
40 
40 
26.0 
122.0 
57.0 
264.0 
17.9 
96.0 
187.0 
124.0 
1010.0 
40.9 
69.7 
168.6 
80.6 
453.1 
27.9 
13.3 
10.3 
15.9 
121.2 
5.1 
 
2.2. The method of the heart dissection and examination 
All 40 hearts with great vessels were fresh without formalin fixation when 
they were dissected. 
For the dissection methods are learned by personal experience and vary 
with the individual pathologist. We took the inflow-outflow trans-valvular 
incisions procedure originally described by Levy, McMillian, and 
Oppenheimer to dissect these hearts [51, 52, 53]. The aorta was opened 
between the attachment of left and right aortic leaflet (Fig.2.1). The 
method taken here is conventional. Each of the four chambers was opened 
according to the blood flow direction, and allows correlating the 
morphology with its function as recorded by clinical investigations [50, 54, 
55, 56].  
 
 
 
 
 
 
 
                                                                                         
               
Fig.2.1: The aorta has been opened to show the outflow tract from the left ventricle. A long incision 
has been made through the anterior wall of the left ventricle between the left and right leaflets to 
show the coronary ostia and aortic leaflets. (From: Malcolm D: Cardiovascular Pathology. Third 
 
 
 
There is a lack of uniformity in the nomenclature of the leaflets and sinuses 
of the aortic valve [56]. In this work, the latter of left, right and posterior 
for description, which advocated by Nomina Anatomica [57] will be 
followed. 
2.3. Heart dissection and measurement of the diameter of the 
distal ascending aorta, the proximal ascending aorta, the 
sinutubular junction (STJ), and the aortic sinus annulus 
During the autopsy, the heart were removed and weighted. The origin of 
the left and right coronary arteries was isolated for measurement of the 
diameter of root portion of the corresponding arteries. In our study, the 
distal ascending aorta was reserved for further analysis and measurement. 
The aortic root including ascending aorta was sectioned sequentially for 
measuring dimensions as below: first, the ascending aorta was 
transversally sectioned approximately 1 cm below the arch of aorta and 
measured the diameter of the distal ascending aorta by using the vernier 
caliper, circle and aortic valve sizer set (Fig.2.2 and Fig.2.3). Second, we 
removed the aorta at level of the proximal aorta, just nearly 1 cm above 
the level of STJ of the aorta, and measured the diameter of the proximal 
aorta, STJ, and sinus valsalva diameter respectively. 
 
 
 
 
 
 
 
Fig. 2.2: Measurement tools:       
vernier caliper and circle 
Fig. 2.3:   Aortic sizer set (diameter 
range 19-29mm) 
 
2.4. Determination the relation of the valved stent, the aortic 
leaflets, and the coronary ostia before the aorta was opened 
After the above measurement was performed, a cut across the aorta 
above the aortic annulus (approximately 0.5 cm above the STJ, avoiding 
the destroy of the coronary ostia which lay above the STJ level) [50] was 
made to exposure the valve architecture in order to look for abnormalities, 
and also to show the orifices of the coronary arteries before the aorta was 
completely opened.  
 
2.4.1. The relation of the valved stent, the aortic leaflets, and the 
coronary ostia before a complete stent deployment 
Before stent implantation we put two needles with a green, a blue or a 
black marker into the left and the right coronary artery ostia. And with the 
aid of forceps and a small metal stick, we observed the relation between 
coronary ostia and aortic leaflets, during the process of the leaflets being 
hold and close to the ostia at different positions, and photographed how 
the coronary ostia would be covered by the aortic leaflets (fully or partially 
covered). 
 
2.4.2. The relation of the valve stent, the aortic leaflets, and the 
coronary ostia after stent implantation 
After taking the pictures of the relation of coronary ostia and aortic leaflets, 
we implanted the appropriate size of an aortic valve stent. This valved 
stent is a collapsible and self-expandable nitinol stent (Fig.2.4) [26]. The 
size of the stent depended on the diameter of the aortic sinus annulus, 
which was measured before valved stent implantation. Then we observed 
the relation of the aortic leaflets, the aortic annulus, the coronary ostia, 
and the valved stent. Photographs documented the coronary ostia 
coverage and/or possible paravalvular leakage after valved stent 
implantation (Fig.2.5). 
 
                                         
 
 
 
       
 
 
Fig.2.4 Aortic valved stent (diameter of nitinol stent range from 25-33 mm) 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.5 This figure represents the valved stent after implantation into the native aortic annulus. 
The aortic leaflets were folded upwards close to the aortic wall.  
2.5. Determination of the parameters and relation of the 
aortic leaflets, the coronary ostia, and the STJ after the aorta 
was opened 
Between the right (anterior) and left (left posterior) aortic leaflets (Fig.2.1), 
the aorta was opened by a longitudinal incision through its anterior wall [54, 
55] to keep the integrity of the coronary ostia and the aortic leaflets. This 
procedure enables the visualization and analysis of the morphology and 
topography of the aortic root structures (including the left and the right 
aortic leaflets, and their corresponding coronary ostia).  Particularly the 
position of the zones of apposition between the leaflets, as well as the 
number and the arrangement of the leaflets, and the position of the 
coronary ostia in relation to the corresponding aortic sinus and the STJ. In 
addition, the coronary arteries were sectioned at the level of their origins in 
the aortic wall. 
2.5.1. Measurement of the aortic root structures: the aortic leaflets 
and the coronary ostia 
 
The coronary ostia in relation to the left and the right aortic leaflet were 
identified and, with the aid of a vernier caliper, the aortic sizer set and a 
circle, the following measurements were taken (Fig.2.6.1-3):  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.6.1: W1,2,3: the width of the aortic leaflets, and the distance between the two attachments of  
leaflet at the STJ (sinutubular junction). L1,2,3: The length of the corresponding aortic leaflets. 
H1,2: The height from the  annulus to the corresponding superior margin of the coronary ostia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 a,b: The distance from the superior margin of coronary ostia to the STJ. 
Fig.2.6.3: H1,2,3: The height of three aortic leaflets from the bottom of sinus annulus to the median 
region of the free edge of the leaflets. a,b: The distance from the right coronary ostia to the bilateral 
corresponding attachment of the leaflets. c,d: The distance from the left coronary ostia to the 
bilateral corresponding attachment of the leaflets. 
Fig.2.6.2: H1,2,3: The height of the aortic sinus annulus to the corresponding STJ. 
1. The diameters of the left and right coronary ostia, and the root portion 
of each coronary artery. 
2. The distance from the coronary ostia to the corresponding attachment of 
the leaflets (left-right commissure, left-posterior commissure and 
right-posterior commissure). 
3. The distance from the aortic sinus annulus to the corresponding superior 
margin of the coronary ostia, and that from the superior margin of 
coronary ostia to the STJ. 
4. The height of the aortic sinus annulus to the corresponding STJ. 
5. The height of three aortic leaflets from the bottom of sinus annulus to 
the median region of the free edge of the leaflet. 
6. The width of the aortic leaflets, and the distance between the two 
attachments of each leaflet at the STJ (it was measured along the inner 
wall of the aorta). 
 
2.5.2. Determination of the position of the coronary ostia in 
relation to the STJ 
In each specimen we observed and recorded the abnormality 
(malformation), position, number, shape of the coronary ostia, and the 
presence of an accessory artery. The left and the right coronary ostia in 
relation to the STJ (inter-commissural line) were observed, and the hearts 
were grouped according to the following parameters: coronary ostium 
above the STJ, below the STJ, and at the level of the STJ. The shape of the 
coronary ostia was described as round, ellipsoidal, and eccentric after the 
heart was displaced flatly on a table. Then we inspected the accessory 
coronary artery, its number and diameter of accessory coronary artery 
were also measured. 
 
2.5.3. Determination of the relation of the coronary ostia and the 
aortic leaflets 
The relation between coronary ostia and aortic leaflets was observed, 
photographed, and the height difference between the coronary ostia and 
the aortic leaflets were measured. It was described and categorized as: 
aortic leaflets covered both ostia; left covered and right not; right covered 
and left not, and no ostium was covered.  
 
2.6. Results and statistical analysis 
The values found in each measurement were listed in tables and the 
results were presented as Means ± SD. Differences between individual 
groups were statistically analyzed. Continuous variables were compared 
by use of paired and 2-tailed unpaired Student t test. Categorical 
variables were presented as frequencies and compared by x2 test. A 
significant difference was accepted when the p-value was less than 0.05.     
 
3. RESULTS 
3.1. General description of the anatomic findings of the aortic 
valve, the coronary arteries, and the coronary ostia  
All 40 heart specimens studied in our study, possessed three semi-lunar 
aortic valves, corresponding sinuses (left, right, and posterior), and three 
intervening commissures. All aortas had two main coronary ostia (internal 
luminal diameter > 2 mm). Not all the coronary arteries originated from the 
appropriated aortic sinuses. The left coronary ostia originated from the left 
aortic sinus in 34 cases (85%), and in 33 cases (82.5%), the right coronary 
ostia originated from the right aortic sinus (Fig. 3.1). The accessory 
coronary opening (<1mm in diameter) was only found in 15 cases (37.5%) 
in the right aortic sinus (Fig.3.1).  
 
 
 
 
 
 
 
 
(anterior leaflet) 
Mitral valve 
LCO 
RCO 
 
Fig 3.1: Diagrammatic representation of the normal aortic valve. The aorta was opened to display 
the three semi-lunar leaflets enface. The right and left coronary artery ostia (RCO, LCO) resigned 
behind the left and right aortic leaflets, which usually lay below and close to the sinutubular junction 
We did not find any arteries taking an epicardial course between the aorta 
and the pulmonary trunk. Data obtained from the latter heart were not 
included in the calculation of the means in this study. 
 
3.2. Measurement of the aorta, the aortic valves, the coronary 
arteries, and the coronary ostia 
3.2.1. The diameter of the distal ascending aorta, the proximal 
ascending aorta, the STJ, and the aortic sinus annulus 
The mean diameter of the distal ascending aorta, the proximal ascending 
aorta, the STJ, and the aortic sinus annulus measured 30.70±4.19 mm 
(range 22.20-41.70 mm), 30.97±4.45 mm (range 21.20-41.50 mm), 
29.86±3.81 mm (range 20.70-39.70 mm), and 23.78±1.69 mm (range 
19.50-27.0 mm), respectively. No significant difference of diameter was 
found among the group of the distal ascending aorta, the proximal 
ascending aorta, and the STJ (Fig.3.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
group
Diameter of sinus 
annulus(mm)
Diameter of sinotubular 
junction (mm)
Diameter of proximal 
 ascending aorta(mm)
Diameter of distal 
 ascending aorta(mm)
me
an
40.00
30.00
20.00
10.00
0.00
Fig.3.2 
On the other hand, there were significant differences between the group of 
the aortic sinus annulus, the distal ascending (p=0.000), the proximal 
ascending aorta, and the STJ (p=0.000). 
 
3.2.2. The diameter of the left and the right coronary ostia, and the 
root diameters of the respective coronary arteries 
The mean diameter of the left coronary ostia and the root of the left 
coronary artery was 5.25±0.80 mm (range 3.75-7.00 mm) and 4.12±0.59 
mm (range 3.0-6.0 mm), respectively. And the mean diameter of the right 
coronary ostia and the root of the right coronary artery measured 
4.73±1.05 mm (range 3.10-8.20 mm) and 3.82±0.58 mm (range 3.0-6.0 
mm). There was no significant difference between the left and the right 
coronary ostia, and same to the left and the right root portion of the 
coronary artery (P>0.05). By paired samples test, there was significant 
difference between the diameter of coronary ostia and that of the root of the 
corresponding coronary artery in the aorta wall (P<0.05). (Fig.3.3, and 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
group
Diameter of left juxtamural 
portion
Diameter of left ostia
di
am
et
er
6.00
5.00
4.00
3.00
2.00
1.00
0.00
Error bars: 95% CI
Fig.3.3 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
group
Diameter of right juxtamural 
portion
Diameter of right ostia
Me
an
6.00
5.00
4.00
3.00
2.00
1.00
0.00
Error bars: 95% CI
Fig.3.4 
3.2.3. The distance between the left, right coronary ostia, and the 
inter-commissures of the aortic leaflets 
The mean distance from the left coronary ostia to the left –right 
inter-commissure and the left-posterior inter-commissure was 10.97±2.49 
mm (range 5.30-17.0 mm) and 10.25±2.95 mm (range 4.50-18.20 mm). 
The mean distance from the right coronary ostia to the left–right 
inter-commissure and the right-posterior inter-commissure was 
13.43±4.13 mm (range 5.50-22.70 mm) and 10.85±4.79 mm (range 
4.70-30.30 mm). There was no difference between the distance from the 
left ostia to the commissure of the left-right and the left-posterior leaflet 
(P>0.05). However, there was a significant difference between the distance 
from the right ostia to the left-right and the right-posterior 
inter-commissures (P<0.05). It showed that the left coronary ostia were 
nearly equally (centrically) distributed in the region of the left aortic sinus, 
while the clustering of the right ostia were towards the right half of the sinus, 
more close to the commissure of the right-posterior leaflet (Tab.3.1, Fig.3.5, 
3.6). 
Tab.3.1: Mean values of the distance between the coronary ostia 
and commissure of the aortic leaflets (mm)  
 
Coronary    Commissure       Mean distance     Mean point of the 
ostia                                            intercommissure distance  
 Left         left-right          10.97±2.49            10.60 
left-posterior      10.25±2.95 
 Right        left-right          13.43±4.13            12.14 
right-posterior    10.85±4.79 
  
 
group
Distance of left ostia to L-P 
commissure
Distance of left ostia to L-R 
commissure
Me
an
12.00
10.00
8.00
6.00
4.00
2.00
0.00
Fig.3.5 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
group
Distance of right ostia to R-P 
commissure
Distance of right ostia to L-R 
commissure
Me
an
15.00
10.00
5.00
0.00
Error bars: 95% CI
Fig.3.6 
3.2.4. The length of the left, the right, and the posterior aortic 
leaflet 
The mean length of left, right, and posterior aortic leaflet measured 
28.92±5.10 mm (range 19.50-37.70 mm), 31.22±6.02 mm (range 
21.20-48.00 mm), and 30.88±5.06 mm (range 23.00-40.50 mm), 
respectively. There was no significant difference between these groups 
(P>0.05).  
 
3.2.5. The relative length of the left, the right, and the posterior 
aortic leaflet at the STJ level 
The mean length of the left, the right, and the posterior aortic leaflet at the 
STJ level measured 24.22±4.03 mm (range 17.60-33.50 mm), 25.75±3.85 
mm (range 19.70-36.00 mm), and 25.69±3.75 mm (range 18.70-40.20 
mm), respectively. There was no significant difference between these 
groups (P>0.05). Based on the result from 3.2.4 and 3.2.5, it means that all 
three aortic leaflets were nearly equally spaced around the aorta. 
3.2.6. The height of the left, the right, and the posterior aortic sinus 
annulus to the related STJ level 
The mean height of the left, the right, and the posterior aortic sinus annulus 
to related STJ level (from the lowest point of aortic sinus annulus to STJ) 
measured were 18.52±2.65 mm (range 12.70-24.20 mm), 18.87±2.55 mm 
(range 13.30-23.70 mm), 18.73±2.62 mm (range 13.00-23.50 mm), 
respectively. There was no significant difference between these groups 
(P>0.05). 
 
3.2.7. The height of the left, the right, and the posterior aortic 
leaflet 
The mean height of the left, the right, and the posterior aortic leaflet (from 
the bottom of the aortic valve to the free ridge of the cusp) measured 
16.11±2.04mm (range 10.70-19.80 mm), 16.36±2.10 mm (range 
11.80-20.00 mm), and 16.77±1.72 mm (range 12.70-21.50 mm). The 
difference is insignificant between these groups (P>0.05). 
 
3.2.8. The height of the left and the right aortic sinus annulus to its 
corresponding coronary ostia (to the superior margin of the ostia) 
The mean height of the left aortic sinus annulus to the left coronary artery 
ostia measured 16.56±2.76 mm (range 10.70-22.20 mm), and that of the 
right aortic sinus annulus to the right ostia was 17.22±3.13 mm (range 
11.30-22.20 mm). There was no significant difference between these two 
groups (P>0.05). 
 
3.2.9. The height of the left and the right coronary artery ostia (from 
the superior margin of the ostia) to its corresponding STJ level  
The mean height of left coronary artery ostia to the related STJ measured 
1.81±1.08 mm (range -2.0-4.70 mm), and the right coronary ostia to STJ 
was 1.78±1.26 mm (range -2.20-4.30 mm). There was no significant 
difference between these groups.  
When both ostia lay in the sinus of valsalva (below the STJ level), the mean 
height of the left ostia to the STJ line measured 1.85±0.64 mm (range 
0.5-3.60 mm), and the right coronary ostia to the STJ was 2.17±0.94 mm 
(range 0.7-4.30 mm). There was a significant difference between the two 
groups (p<0.05). It means that the right ostia are located at a lower position 
than the left coronary ostia in the sinus of valsalva. 
 
3.3. The location, the number, and the shape of the coronary 
ostia in relation to the STJ  
In our study, the malformation, location, number, and shape of the coronary 
orifices and the presence of accessory orifices were observed and recorded. 
The location of the left and the right coronary ostia were measured in 
relation to the STJ and described as being below, above, and at the level of 
the STJ. The cases and percentage of coronary ostia in relation to STJ line 
were listed in table 3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tab.3.2: Left and right coronary ostia below, above, or at the STJ 
level (n=40) 
 
Location of the coronary ostia with respect to the STJ level 
Coronary ostia                              Cases              %  
Both below                                   29               72.5 
Both above                                   1                2.5 
Both at level                                  0                0 
Left above, Right below                       2                5 
Left above ,Right at level                      1                2.5 
Left below ,Right above                       2                 5 
Left below ,Right at level                      3                7.5 
Left at level, Right below                      2                 5 
Left at level ,Right above                      0                 0 
 
The shape of the coronary ostia was described as round, crescentic, and 
ellipsoidal. The orifice of the left coronary artery was round in 26 cases 
(65%), ellipsoidal in 10 cases (25%), and crescentic in 4 cases (10%). The 
orifice of the right coronary artery was round in 28 cases (70%), ellipsoidal 
in 9 cases (22.5%), and crescentic in 3 cases (7.5%). Within the right aortic 
sinus 15 cases (37.5%) had an accessory artery, and 4 cases (10%) had 
another smaller artery. No additional artery orifice was found in the left 
aortic sinus. No isolated nourishing artery of the right ventricular 
infundibulum (conus artery) was observed. The pictures of the position and 
shape of the coronary ostia were shown below (Fig.3.7; 3.8; 3.9; 3.10; 
3.11,3.12). 
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Fig 3.7: Both coronary ostia below the sinutubular junction, and the shape were circular. 
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Fig.3.8: The left coronary ostium below STJ line, and the right ostium on the STJ line in 
ellipsoidal shape. 
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Fig.3.9: The left coronary ostium was located at the STJ line, and a crescentic right 
ostium was below the STJ line. We found an accessory artery () within the right aortic 
sinus, just next to right main artery orifice; the diameter was 0.8 mm. 
 
 
 
A.  
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Fig.3.10: The left coronary ostium was located above the STJ line, and the right ostium 
below the STJ line. An accessory artery () within the right aortic sinus, at the left side 
of right main artery orifice; the diameter was 0.5 mm. 
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Fig 3.11: The left coronary ostium was below the sinutubular junction, round shape. The 
right ostia above STJ line, crescentic shape. 
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Fig 3.12: The left and right coronary ostia were above the STJ line. 
3.4. The difference between the height of the left and the right 
aortic leaflet and the height of its corresponding sinus annulus 
to the ostia 
Both of the height value differences were positive in seven cases (17.5%, 
four male and three female). Both were negative in eighteen cases (45%, 
six male and twelve female). There were five cases (12.5%, two male and 
three female) with positive left value and negative right value. Meanwhile, 
ten cases (25%, six male and four female) had a right positive value and a 
left negative value.  
Theoretically, if the height of the aortic leaflet is higher than that of the 
aortic annulus to its corresponding STJ, the difference of the height is 
positive. This phenomenon might result in covering the coronary ostium by 
the aortic leaflet. While the height difference is negative, the ostium might 
not be covered (Tab. 3.3). 
 
Tab.3.3: The cases and the percentage of the ostia were covered by 
the leaflet (n=40) 
  
Cases 
 
Male 
 
Female 
Both ostia covered 
Left ostia covered, right not 
Right ostia covered, left not 
Both ostia  not covered 
7 
5 
10 
18 
4 (10%) 
3 (7.5%) 
6 (15%) 
6 (15%) 
3 (7.5%) 
2 (5%) 
4 (10%) 
12 (30%) 
Total 40 19 (47.5%) 21 (52.5%) 
 
Totally there were eleven cases (see Tab.3.3), which the coronary ostia 
were located at or above the STJ. Only one of eleven cases (9.1%), the right 
coronary ostium was covered by the right leaflet. The other ten of eleven 
cases (90.9%); the coronary ostia were located at or above the STJ level 
and were not covered. 
The coronary ostia, which were located in the aortic sinus (below the STJ 
line), the following ostia were covered: 17 of 29 cases (65.5%) of the right 
ostia, and 12 of 29 cases (41.3%) of the left ostia. 
In our study there was no difference between male (19, 45%) and female 
(21, 55%).  Interestingly, that in the group of one or both ostia was 
covered by the aortic leaflet, male had 13 (13/19, 68%) cases, while female 
in 7 (7/21, 33.3%) cases. It had significant difference (P<0.05).  
We analyzed the correlation between the height difference (height of each 
aortic leaflet and height of the aortic sinus annulus to the corresponding 
superior margin of the ostia) and other factors which we have measured. 
The statistic results of correlation were shown in table 3.4 and 3.5. 
Correlation was significant at the 0.05 level (2-tailed). 
 
 
 Tab.3.4: The correlation of the difference of the height of the left 
cusp to the height of the left annulus to ostia with other 
parameters 
 
 
Variable 
Difference ofheight of left cusp-height of 
left annulusto ostia 
  
Pearson Correlation 
 
Sig. (2-tailed) 
Age 
Height 
Body weigh 
Body mass index 
Heart weight 
Diameter of  STJ 
Diameter of annulus 
Diameter of left ostia 
Distance difference of left 
ostia to commissure 
Length of left cusp 
Circumference of STJ 
Height of left annulus to ostia 
Height of left ostia to STJ 
Height of left cusp 
Height of left annulus to STJ 
-.273 
.147 
.092 
.144 
-.264 
.033 
.187 
-.238 
.347* 
 
-.002 
.196 
-.701** 
.587** 
.165 
-.644** 
.089 
.365 
.571 
.377 
.100 
.838 
.248 
.139 
.028 
 
.992 
.542000 
.000 
.000 
.309 
.000 
 
*: Correlation is significant at the 0.05 level (2-tailed). 
**: Correlation is significant at the 0.01 level (2-tailed). 
 
 Tab.3.5: The correlation of the difference of the height of the right 
cusp to the height of the right annulus to ostia with other 
parameters 
 
Variable 
Difference of the height of the right cusp- 
the height of the right annulus to ostia 
  
Pearson Correlation 
 
Sig. (2-tailed) 
Age 
Height 
Body weigh 
Body mass index 
Heart weight 
Diameter of  STJ 
Diameter of annulus 
Diameter of right ostia 
Distance difference of 
rightostia to commissure 
Length of right cusp 
Circumference of STJ 
Height of right annulus to 
ostia 
Height of right ostia to STJ 
Height of right cusp 
Height of right annulus to STJ 
-.001 
.036 
.216 
.303 
-.186 
.036 
.064 
-.160 
-.264 
 
-.310 
.086 
-.650** 
.584** 
.112 
-.514** 
.996 
.826 
.181 
.057 
.250 
.824 
.697 
.324 
.099 
 
.052 
.770 
.000 
.000 
.493 
.001 
 
*: Correlation is significant at the 0.05 level (2-tailed). 
**: Correlation is significant at the 0.01 level (2-tailed). 
3.5. The findings of the relation among the aortic leaflet, the 
coronary ostia, and the valve stent before and after valved 
stent implantation 
In our study, three steps were undertaken to illustrate the relation of the 
coronary ostia, the aortic leaflets, and the valve stent. First, the relation 
between coronary ostia and leaflets were measured before the stent was 
implanted. Second, we observed the relation among the coronary ostia, 
leaflets, and stents after the stent implantation in the aortic annulus position. 
Finally, when the aorta was opened, we inspected if the aortic leaflets would 
or would not cover the coronary ostia. The results were categorized 
described and as: both ostia were covered (Fig.3.13); right covered, left not 
(Fig.3.14); and left covered, right not (Fig.3.15). 
  
3.5.1. Both coronary ostia were covered (Fig.3.13) 
3.5.1(1): Before the stent implantation 
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Fig.3.13 (a): The left coronary ostium was covered by the left aortic leaflet. 
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3.5.1(2): After the stent implantation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.13(b): The rig ronary ostium was covered by the right aort flet.          ht co ic lea→ →
→ →
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Fig.3.13(c):   The left coronary ostium was covered by the aortic leaflet after stent 
implantation. 
RCO 
→
RCO 
→
implantation. 
Fig. 3.13(d): The right coronary ostium was covered by the leaflet after stent  
 
3.5.1(3): After the aorta was opened. 
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Fig. 3.13(e): The aorta was opened by a longitudinal incision through its anterior wall  
between the commissure of the left and right aortic leaflet. The green needle is in the left  
ostium, and the blue one in the right ostium.  
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Fig.3.13 (f, g): The left and the right ostia were covered by the aortic leaflets when it was  
tightened by a forceps. 
→
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3.5.2. Right ostia covered, left not (Fig.3.14) 
.5.2(1): Before the stent implantation 
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Fig.3.14 (a): The left coronary ostia were not covered by the aortic leaflet. 
Fig.3.14 (b): The right coronary ostia were covered by the right aortic leaflet. 
→
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3.5.2(2): After the stent implantation                                    
      
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.14(c): The left coronary ostia were not covered by the aortic leaflet after stent  
imp ntation. la
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.2(3): After the aorta was opened. 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.14 (d): The right coronary ostia were covered by the aortic leaflet after stent 
implantation. 
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Fig.3.14 (e, f): The right ostia (with green needle marked) were covered by the aortic 
leaflets when it was tightened by a forceps. But the left ostia can’t be presented because 
of the broken of left leaflet. 
3.5.3. Left ostia covered, right not (Fig.3.15) 
 
3.5.3(1): Before the stent implantation 
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Fig.3.15 (a): The left coronary ostia were covered by the aortic leaflet. 
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Fig.3.15 (b): The right coronary ostia were not covered by the aortic leaflet. 
 
3.5.3(2): After the stent implantation  
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Fig.3.15 (c) Fig.3.15 (d)  
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marker) were not covered. 
which were by the aortic leaflet after stent implantation, while the right ostia (blue needle  
Fig.3.15 (c, d, e): The figures illustrated the covered left coronary ostia (green marker), 
3.5.3(3): After the aorta was opened  
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Fig.3.15 (f): The aorta was opened between the left and right aortic leaflet commissure. 
The green needle is in the left ostium, and the blue one in the right ostium.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
→
LCO →
RCO 
Fig.3.15(g): The left coronary ostium was covered by the aortic leaflet when it was 
tightened by a forceps, while the right ostium was not covered.  
4. DISCUSSION  
In elderly patients with declining overall health status or life-threatening 
co-morbidities, aortic valve replacement is considered either too risky or 
contraindicate, because of the significant risk of morbidity and mortality [5, 
6, 7]. Furthermore, symptomatic patients with severe aortic stenosis 
managed medically have a poor prognosis [58, 59].  As an alternative, the 
percutaneous balloon aortic valvuloplasty is palliative and with a certain 
restenosis [60, 61], although it may result in temporary improvement of 
valvular function and relief of symptoms. 
Given the limited therapeutic options in this subset of patients, there were 
remarkable developments of percutaneous aortic valve implantation by a 
retrograde or antegrade approach [24, 25, 30]. However, the technical 
complexity and risks such as impairment of coronary blood flow and 
paravalvular leakage, associated with percutaneous and transapical aortic 
valve replacement appear significantly limit its widespread application [8, 9, 
30]. 
Coronary flow impairment (restriction), as a major issue encountered in 
PAVR, might be caused by the obstruction of coronary ostia by the native 
leaflets, which was firstly reported by Andersen in 1992. Late on, many 
investigators [9, 26, 35] took numerous efforts to study this problem in 
experimental animal model, however, different conclusion were drawn from 
these studies. Currently, Flecher et al [46] reported their study results in 
vitro, showed that the deployment of a cylindrical, stented aortic valve can 
severely affect coronary flow by obstructing the coronary ostia with the 
native leaflets. During orthotopic PAVI, obstruction of coronary ostia with 
coronary flow restriction can occur either by direct blocking from the 
implanted stent, or from the native aortic leaflets immobilized against the 
coronary orifices [8, 9, 26, 27, 31, 38]. Based on this, we observed and 
investigated the anatomy of aortic root structures, to elucidate the relation 
of aortic root structures and valved stent, and the influence of valved stents 
on these anatomic structures by post mortem aortic valve stent 
implantation.  
4.1. The anatomy of the aortic root structures 
Our study, which comprised a series of 40 heart specimens, confirms that 
the three semi-lunar aortic leaflets of all hearts were nearly equally spaced 
around the aorta, corresponding valsalva sinuses (left, right, and posterior, 
respectively), and three intervening commissures. And the aorta had two 
main coronary ostia which arose from the appropriated aortic sinus [47, 49, 
50]. Most of the ostia were round shape. The accessory coronary arteries 
were found in right aortic sinus only. No variation of coronary ostia was 
found in our case series, which differs from the study of Jatene MB et al [62], 
in which they reported 1-2% of hearts had both 2 ostia originated from left 
aortic sinus. 
Muriago et al [50] indicated that the coronary orifices are not located in the 
center of each aortic sinus. On the contrary, both coronary orifices are 
displaced to the commissure located to the right of the ostia, and close to 
the level of the free edge of the aortic leaflets. However, in our series, on 
average, the left coronary ostia cluster near to, albeit not precisely at, the 
central region of the left sinus curvature; while the right coronary ostia tend 
to locate a little further laterally, in the right side of the sinus, more close to 
left-posterior inter-commissure. Our results are in accordance with the 
studies reported by Cavalcanti et al [40] and Turner and Navaratnam [49].  
Regarding the position of the coronary ostia in relation to the STJ, 29 of 40 
analyzed hearts (72.5%) had both ostia located in the aortic sinus, and 11 of 
40 hearts (27.5%) had one or both ostia above or at the STJ level. Of the 80 
ostia, 67/80 ostia (83.7%) were located below the STJ level, only 6/80 ostia 
(7.5%) were at its level, and 7/80 ostia (8.8%) above it. These results are 
similar to the study by Muriago et al [50], in which they reported 3 of 23 
hearts (13%), the ostia at or above that level. On the other hand, our results 
differ from those of Cavalcanti et al [40], which indicated that 34 of 50 
studied hearts (68%) had one or both ostia above or at the STJ level, while 
both ostia were located below the level only in 32% of cases. Moreover, our 
study also differs from the study by Waller et al [63], who had noted up to 
three-tenths of coronary orifices arising above the STJ. 
Regarding the left and right coronary ostia, our results are significantly 
different from those by Cavalcanti et al [40], who reported a left coronary 
ostia were below the STJ in 42%, at or above that level in 58% (18% at level, 
40% above level), while the right coronary ostia were below the STJ in 60%, 
at or above that level in 40% (12% at level, 28% above level) in their 
studies, respectively. In our case series, the left ostia located were below 
the STJ in 85% (34/40), at or above the level in 15% (15/40, 5% at level 
and 10% above the level), while the right coronary ostia were below the 
level in 82.5% (33/40), at or above the level in 17.5% (7/40, 7.5% at level 
and 10% above the level), which is similar to the results studied by Muriago 
et al [50]. 
In our study, when the coronary ostia were located in the corresponding 
aortic sinus, most of the left ostia had typical vertical and circumferential 
positions in relation to the aortic leaflets, sinus and STJ. On the other hand, 
the right ostia were located more eccentrically at a lower position in its aortic 
sinus regarding to the left ostia, which almost centrically distributed in a 
higher position of the aortic sinus. From the functional point of view, Turner 
[49] described the phenomena as the typical vertical and centrically 
positioning of the ostia, particularly when both coronary ostia were lying 
above the STJ level. This might confer functional advantages for coronary 
flow during ventricular systole and also prevent the obstruction of the ostia, 
when the aortic valve was opened. 
4.2. The findings of post mortem aortic valved stent 
implantation into the aortic position  
When the valved stents were properly implanted into the post mortem aortic 
annulus, we found the native aortic leaflets were obviously folded upwards, 
pushed and immobilized by the valved stents against the aortic wall. The 
space of aortic valsalva sinus was narrowed. Most of the coronary ostia were 
partially or fully covered by its native leaflets. Most of the aortic leaflets and 
annulus were without severe calcification and stenosis - therefore 
paravalvular leakages were rarely found. 
In 22 of 40 cases (55%) of our post mortem study, one or both coronary 
ostia were covered by the aortic leaflets after stents implantation (both 
covered in 7 cases, left in 5 cases, and right in 10 cases). Among them, 21 
of 29 cases (72.4%), if both coronary ostia were located below the STJ, the 
ostia were fully covered by the aortic leaflets. The right ostia were located at 
the STJ level in 1 of 11 cases (9.1%) and were covered. The remaining 10 
cases with one or both ostia located at or above the STJ level did not show 
any ostia covered.  Regarding to the respective ostia, 28 of 67 ostia (41.8%) 
below the STJ were covered, whereas only 1 of 13 ostia (7.7%) located at or 
above the STJ level, was covered. That means if the coronary ostia lay below 
the STJ or in the aortic sinus, there was a higher frequency to be covered by 
their leaflets if the ostia were located at or above the STJ level. According to 
our observation, the height of each leaflet and that of the corresponding 
annulus to the STJ were nearly equal. The different distribution of the ostia 
in relation to its STJ may result in such contradistinctive outcome. 
In total, 28 of 67 ostia (41.8%) were located below the STJ and were fully 
covered. Connecting the individual ostia, 12 of 34 left ostia (35%) were 
covered, and 16 of 33 right ostia (48.5%) were covered by its corresponding 
aortic leaflets. Although there was no significant statistic difference between 
them, we found that the right coronary ostia were more easily covered by 
the leaflets. Based on our observation and investigation after the aortas 
were opened, we considered that the eccentrically distribution of right ostia 
in aortic sinus and the location in a lower position of the sinus compared to 
the left ostia might be the possible explanation.  
After stent implantation into the aortic annulus, the aortic leaflets were 
folded upwards and immobilized against the aorta wall, similar to the aortic 
leaflet position during the measurement after the aorta was opened. 
According to our observation and measurement of the aortic root structures, 
the results after implantation demonstrated the relation between the valved 
stent and the aortic root structures. 
Theoretically, the ostium would be covered by its corresponding leaflet if the 
height of the leaflet is greater than the height of the aortic annulus to the 
ostium, otherwise the ostium would not be covered. Here, we found the 
positive correlation among the height difference, the height of leaflets, and 
distance from the annulus to the ostium. Furthermore, our data suggest the 
negative correlation between the height difference and the distance of the 
coronary ostia to the STJ level. It might explain that the ostia which were 
located below the STJ level had a higher frequency to be covered by its 
leaflets. This might also support our finding if the ostia were located below 
the STJ, the right ostia were covered more often than the left one. 
To avoid the impairment of coronary flow in the clinical situation, we assess 
the risk caused by ostia coverage through measuring the aortic root 
structure by echocardiography [64], CT scan or MRIA techniques before the 
orthotopic PAVR or PAVI. Recently, Quaden et al [27] reported the feasibility 
of endovascular resection of human calcified aortic valves by using a 
high-pressure water stream scalpel and a thulium:YAG laser. And they 
firstly performed the endovascular resection of human aortic valves in situ 
through an Aortic Valve Isolation Chamber (AVIC) system [37], although 
the capture of debris is required to prevent embolism. 
So, to perform a reliable PAVR, resection of the diseased native leaflets 
before implantation is necessary and feasible. However, resection of none 
diseased valves is also necessary sometimes because implanting a new style 
stent to these valves might cover the ostia by crimping the leaflets after 
implantation of the stent. 
 
4.3. Limitations 
In the present study of 40 post mortem hearts, most of the aortic leaflets 
and annulus tissue were normal or with mild calcification. However, in 
clinical application of percutaneous aortic valved stent implantation, the 
candidates have severe aortic stenosis mainly caused by sclerosis and mild 
to moderate calcification. It is necessary to perform a further study on these 
cases, which are missing in our study for the reason that a main part of 
these patients will already be operated on their aortic valve stenosis. 
In our study, in vitro post mortem aortic valved stent implantation has been 
performed. It will be more physiological related, if we could study in a 
dynamic and physiological environment in vivo. Regarding this aspect, the 
implantation in post mortem human anatomy is an essential science. 
Performing a study by using a different style of valved stents will be further 
required. Then, we can compare the options of newly designed valved stents 
and resection of the native leaflets before implantation.  
It is necessary to find a more feasible imaging method to represent and 
demonstrate the aortic root structures, the valved stents and their 
relationship. The difficulty of representation of the relation between the 
coronary ostia, aortic leaflets, and valved stents were encountered in our 
study. 
4.4. Conclusion 
In conclusion, the current study demonstrated that most of the coronary 
ostia were located below the STJ level, only very few coronary ostia were at 
or above the same. The left coronary ostia cluster centrically, and near to 
the central region of the sinus curvature; while the right coronary ostia tend 
to locate eccentrically, a lower position, and in the right side of the sinus. 
Most of the coronary ostia, which were located below the STJ, were covered 
by its corresponding aortic leaflets; while the ostia were rarely covered by 
the aortic leaflets when they lay at or above the STJ. The right coronary ostia 
have a greater frequency to be covered by their aortic leaflets than left ones. 
The native aortic leaflet is the main cause of obstruction of coronary ostia in 
post mortem orthotopic aortic valved stent implantation. To perform an 
orthotopic PAVR, resection of the native leaflets before the implantation 
might be necessary and new stents have to be designed to prevent coverage 
of the coronary ostia by crimping the leaflets. 
 
5. Summary 
Background: Previous studies have suggested that the close proximity of 
the coronary orifice to the aortic valve leaflets made percutaneous and 
transapical aortic valve implantation a major challenge such as coronary 
flow impairment. In this study, the aortic root structures were observed and 
measured in human cadavers. 
Material and Methods: We assessed the diameter of the distal ascending 
aorta, the proximal ascending aorta, the STJ, the aortic annulus, the 
coronary ostia, and the distance of the annulus to the coronary ostia, the 
coronary ostia to the STJ level, each ostium to its bilateral commissure of 
the aortic leaflet, the height of the aortic leaflets, and the aortic annulus to 
the STJ level. Meanwhile, the malformation, location, number, and shape of 
the coronary artery orifices and the presence of accessory orifices were 
observed and recorded. During the study, the relation of the coronary ostia, 
the aortic leaflets, and the valved stent were also investigated through the 
post mortem aortic valved stent implantation. 
Results: The results demonstrated that most of the coronary ostia were 
located below the STJ level, only very few coronary ostia were at or above 
the same. The left coronary ostia cluster near to the central region of the 
sinus curvature, while the right coronary ostia tend to locate eccentrically, a 
lower position, and in the right side of the sinus. Most of the coronary ostia, 
which were located below the STJ, were covered by its corresponding aortic 
leaflets; while the ostia were rarely covered by the aortic leaflets if they lay 
at or above the STJ. The right coronary ostia were more frequently covered 
by its aortic leaflets than the left ones.  
Conclusion: To perform an orthotopic PAVR, resection of the native leaflets 
before implantation of the valved stent might be necessary and new stents 
have to be designed to prevent coverage of the coronary ostia by crimping 
the leaflets. 
6. References 
1. Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, 
Schmitz W, Kubler W. The effect of aortic valve replacement on survival. 
Circulation. 1982; 66:1105–1110. 
2. Bridgewater B, Stevn RS, Ray S, Hooper T. Minimally invasive aortic 
valve replacement through a transverse sternotomy: a word of caution. 
Heart. 1998; 79:605-607. 
3. Grossi EA, Galloway AC, Ribakove GH. Impact of minimally invasive 
valvular heart surgery: a case-control study. Ann Thorac Surg. 2001; 
71:807–810. 
4. Gulbins H, Pritisanac A, Hannekum A. Minimally invasive heart valve 
surgery: already established in clinical routine? Expert Rev Cardiovasc 
Ther. 2004; 2:837-843. 
5. Mullany CJ. Aortic valve surgery in the elderly. Cardiol Rev. 2000; 
8:333–339. 
6. Feldman T. Percutaneous valve repair and replacement: challenges 
encountered, challenges met, challenges ahead. Circulation. 2006; 
113:771-773. 
7. Iskandrian AS, Segal BL. Should cardiac surgery be performed in 
ctogenarians? J Am Coll Cardiol. 1991; 18:36-37. 
8. Lutter G, Ardehali R, Cremer J, Bonhoeffer P. Percutaneous valve 
replacement: current state and future prospects. Ann Thorac Surg. 2004; 
78:2199–2206. 
9. Boudjemline Y, Bonhoeffer P. Steps toward percutaneous aortic valve 
replacement. Circulation. 2002; 105:775-778. 
10. Kan JS, White RI Jr, Mitchell SE, Gardner TJ. Percutaneous balloon 
valvuloplasty: a new method for treating congenital pulmonary-valve 
stenosis. N Engl J Med. 1982; 307:540–542. 
11. Kan JS, White RI Jr, Mitchell SE, Anderson JH, Gardner TJ. Percutaneous 
 transluminal balloon valvuloplasty for pulmonary valve stenosis. 
 Circulation. 1984; 69:554-560. 
12. Iung B, Garbarz E, Michaud P. Late results of percutaneous mitral 
 commissurotomy in a series of 1024 patients: analysis of late clinical 
 deterioration: frequency, anatomic findings, and predictive factors.  
 Circulation. 1999; 99:3272–3278. 
13. Lababidi Z, Wu JR, Walls JT. Percutaneous balloon aortic valvuloplasty: 
 results in 23 patients. Am J Cardiol. 1984; 53:194–197. 
14. Letac B, Cribier A, Koning R. Aortic stenosis in elderly patients aged 80 
or  older: treatment by percutaneous balloon valvuloplasty in a series of 
92  cases.  Circulation. 1989; 80:1514–1520. 
15. Eltchaninoff H, Tron C, Cribier A. Effectiveness of percutaneous 
 mechanical mitral commissurotomy using the metallic commissurotomy 
 in patient with restenosis after balloon or previous surgical 
 commissurotomy. Am J Cardiol. 2003; 91:425–428. 
16. Kaye DM, Byrne M, Alferness C, Power J. Feasibility and short-term 
 efficacy of percutaneous mitral annular reduction for the therapy of 
heart  failure-induced mitral regurgitation. Circulation. 2003; 
108:1795–1797. 
17. Bonhoeffer P, Boudjemline Y, Saliba Z, Hause AO, Aggoun Y, Bonnet D. 
Transcatheter implantation of a bovine valve in pulmonary position: a 
 lamp study. Circulation. 2000; 102:813-816. 
18. Moazami N, Bessler M, Argenziano M, Choudlhi AF, Cabreiza SE, 
Allendorf JD, Rose EA, Oz MC. Transluminal aortic valve placement. A 
feasibility study with a newly designed collapsible aortic valve. ASAIO J. 
1996; 42:381-385. 
19. Attmann T, Quaden R, Jahnke T, Muller-Hulsbeck S, Boening A, Cremer J, 
 Lutter G. Percutaneous pulmonary valve replacement: 3-month 
evaluation of self-expanding valved stents. Ann Thorac Surg. 2006; 
82:708-713. 
20. Bonhoeffer P, Esteves C, Casal U. Percutaneous mitral valve dilatation 
with the multi-track system. Catheter Cardiovasc Interv. 1999; 
48:178–183. 
21. Block P, Palacios IF. Clinical and hemodynamic follow-up after 
percutaneous aortic valvuloplasty in the elderly. Am J Cardiol. 1988; 
62:760–763. 
22. McKay RG. The Mansfield Scientific Aortic Valvuloplasty Registry: 
overview of acute hemodynamic results and procedural complications. J 
Am Coll Cardiol. 1991; 17:189–192. 
23. Bonhoeffer P, Boudjemline Y, Qureshi S.  Percutaneous insertion of the 
pulmonary valve. J Am Coll Cardiol. 2002; 39:1664–1669. 
24. Cribier A, Eltchaninoff H, Bash A. Percutaneous transcatheter 
implantation of an aortic valve prosthesis for calcific aortic stenosis: first 
human case description. Circulation. 2002; 106:3006–3008. 
25. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, 
Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with 
percutaneous transcatheter implantation of heart valve prosthesis for 
the treatment of end-stage inoperable patients with calcific aortic 
stenosis. J Am Coll Cardiol. 2004; 43:698–703. 
26. Lutter G, Kuklinski D, Berg G, Von Samson P, Martin J, Handke M, 
Uhrmeister P, Beyersdorf F. Percutaneous aortic valve replacement: an 
experimental study. I. Studies on implantation. J Thorac Cardiovasc Surg. 
2002; 123:768–776. 
27. Quaden R, Attmann T, Boening A, Cremer J, Lutter G. Percutaneous 
aortic valve replacement: resection before implantation. Eur J 
Cardiothorac Surg. 2005; 27:836-840. 
28. Hufnagel CA, Harvey WP, Rabil PJ. Surgical correction of aortic 
insufficiency. Surg. 1954; 35:673–683. 
29. Stavropoulos S. Davies H. The contour of the subvalvular pressure curve 
in subaortic stenosis. Br Heart J. 1965l; 27:540-546. 
30. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of 
 artificial heart valves Description of new expandable aortic valve and 
 initial results with implantation by catheter technique in closed chest 
pigs.  Eur Heart J. 1992; 13:704–708. 
31. Pavcnik D, Wright KC, Wallace S. Development and initial experimental 
 evaluation of a prosthetic aortic valve for transcatheter placement: work 
 in progress. Radiology. 1992; 183:151-4. 
32. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, 
 Acar P, Le Bidois J, Sidi D, Kachaner J. Percutaneous replacement of 
 pulmonary valve in a right-ventricle to pulmonary-artery prosthetic 
 conduit with valve dysfunction. Lancet. 2000; 356:1403–1405. 
33. Lutter G, v Samson P, Kuklinski D. A new percutaneous transluminal 
 technique for minimal aortic valve replacement. Circulation. 2001; 
 104:II-552. 
34. Boudjemline Y, Bonhoeffer P. Percutaneous valve insertion: a new 
 approach? J Thorac Cardiovasc Surg. 2003; 125:741–742. 
35. Huber CH, Tozzi P, Carno AF. Do valved stents compromise coronary 
flow?  Eur J Cardiothorac Surg.2004; 25:754-759. 
36. V Herwerden LA, Serruys PW. Percutaneous valve implantation: back to 
 the future? Eur Heart J. 2002; 23:1415–1416. 
37. Quaden R, Klaws GR, Dirk TK, Lutter G.  Percutaneous aortic valve 
 replacement: first endovascular resection of human aortic valves in situ. 
 Eur Cardiothoracic Surg. 2007; 31:305. 
38. Samuel V. Lichtenstein, Cheung A, Jian Ye, Christopher R. Thompson, 
 Ronald; Transapical Transcatheter Aortic Valve Implantation in Humans: 
 Initial Clinical Experience. Circulation. 2006; 114:591-596. 
39. Huber CH, Cohn LH, von Segesser Lk. Direct-access valve replacement: 
 A novel approach for off-pump valve implantation using valved stents. J 
 Am Coll Cardiol. 2005; 46:366-370. 
40. Cavalcanti JS, de Melo NC, de Vasconcelos RS. Morphometric and 
 topographic study of coronary ostia. Arq Bras Cardiol. 2003; 
 81(4):359-62, 355-8. 
41. Anderson RH. Clinical anatomy of the aortic root. Heart. 2000; 
 84:670-673. 
42. Choo SJ, Mcrae G, Olomon JP. Aortic root geometry: pattern of 
 differences between leaflets and sinuses of Valsalva.  J Heart Valve Dis.  
 1999; 8:407-415. 
43. Yacoub MH, Kilner PJ, Birks EJ. The aortic outflow and root: a tale of 
 dynamism and crosstalk. Ann Thorac Surg. 1999; 68(suppl): S37-43. 
44. Lerer PK, Edwards WD. Coronary arterial anatomy in bicuspid aortic 
 valve: necropsy study of 100 hearts. Br Heart J. 1981; 45:142-147. 
45. Gonzales-Angulo A, Reyes HA, Wallace AS. Anomalies of the origin of the 
 coronary arteries (special reference to single coronary artery).  
 Angiology. 1966; 17:96-103. 
46. Flecher E M, Curry J W, Joudinaud TM, Kegel CL, Weber PA, Duran C MG. 
 Coronary flow obstruction in percutaneous aortic valve replacement. An 
 in vitro study. Eur J Cardiothorac Surg. 2007; 32:291-294. 
47. Anderson RH, Becker AE. An integrated text and colour atlas. 1980.3. 
 London: Churchill Livingstone.  
48. Reid K. The anatomy of the sinus of Valsalva. Thorax.1970; 25: 79-85. 
49. Turner K, Navaratnam V. The positions of the coronary arterial ostia. 
Clin  Anat. 1996; 9: 376-80. 
50. Muriago M, Sheppard MN, Ho SY. Location of the coronary arterial 
orifices in the normal heart. Clin Anat. 1997; 10:297-302. 
51. Lev M, McMillan JB: A semiquantitative histopathologic method for the 
study of the entire heart for clinical electrographical correlations. Am 
heart J. 1959; 58:140. 
52. Oppenheimer BS: A routine method of opening the heart with   
 conservation of the bundle of His and the sinoauricular node .JAMA 
1912; 59:937. 
53. Chapman CB: On the study of the heart. A comment on autopsy 
 techniques. Arch Intern Med. 1964; 113:318. 
54. Silver MM, Freedom MM. Gross examination and structure of the heart. 
 In: Silver MD. Cardiovascular Pathology. New York: Churchill 
 Livingstone. 1991:1-42. 
55. Malcolm D, Silver MM. Cardiovascular Pathology. Third Edition: 1-29. 
56. Anderson RH, Becker AE. Normal cardiac anatomy. The cardiovascular 
system. Part A: General consideration and congenital malformations. 
Edinburgh: Churchill Livingstone. 1993;3-26. 
57. Nornina Anatomica. 1989 6th edition. Edinburgh: Churchill 
Livingstone. 
58. ACC/AHA. ACC/AHA. Guidelines for the management of patients with 
valvular disease: a report of the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines 
(Committee on Management of Patients with Valvular Heart Disease). J 
 Am Coll Cardiol. 1998; 32:486 –588. 
59. Otto CM, Mickel MC, Kennedy JW, Alderman EL, Bashore TM, Block 
 PC, Brinker JA, Diver D, Ferguson J, Holmes DR Jr. Three-year 
outcome  after balloon aortic valvuloplasty: insights into prognosis of 
valvular  aortic stenosis.  Circulation. 1994; 89:642– 650. 
60. Feldman T. Core curriculum for interventional cardiology: percutaneous 
 valvuloplasty. Catheter Cardiovasc Interv. 2003; 60:48 –56. 
61. O’Neill WW. Predictors of long-term survival after percutaneous aortic 
 valvuloplasty: report of the Mansfield Scientific Balloon Aortic 
 Valvuloplasty Registry. J Am Coll Cardiol.  1991; 17:193–198. 
62. Jatene MB, Monteiro R, Guimarães MH. Avaliação da valva aórtica. 
 Estudo anatômico em 100 corações humanos normais. Arq Bras 
Cardiol.   1999; 73: 75-86. 
63. Waller BF, Orr CM, Slack JD, Pinkerton CA, van Tassel J, Peters T. 
 Anatomy, histology, and pathology of coronary arteries: A review 
 relevant to new interventional and imaging techniques—Part I. Clin. 
 Cardiol.1992; 15:451–457. 
64. Islam MN, Khan ZI, Khan, SR, Haque MA. Morphometry of the 
 intercommissural distances and other structures of the aortic valve 
of  bovine heart. Mymensingh Med J. 2006; 15:153-8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Appendix 
All the patients’ general characteristics including gender, height, body 
weight, heart weight and main cause of death are list below: 
1. Gender: female;        Age: 75Ys;             Height: 165cm         
   Body Weight: 65kg            Heart weight: 389g.      
Diagnosis: Post-op CABG, multiple organs failure. 
2. Gender: female;        Age: 85ys;             Height: 164cm         
   Body Weight: 57 kg            Heart weight: 343 g.      
Diagnosis: advanced lung cancer, multiple organs metastasis. 
3. Gender: male;        Age: 56ys;             Height: 178cm         
   Body Weight: 89kg            Heart weight: 451 g.      
Diagnosis: unknown, multiple organs failure? 
4. Gender: male;        Age: 53ys;             Height: 168cm         
   Body Weight: 72 kg            Heart weight: 373g.      
Diagnosis: chronic obstructive pulmonary disease. 
5. Gender: male;        Age: 65ys;             Height: 165 cm         
   Body Weight: 100kg            Heart weight: 425g.      
Diagnosis: post-op of ECMO. 
6. Gender: male;        Age: 54ys;             Height: 180 cm         
   Body Weight: 67kg            Heart weight: 480g.      
Diagnosis: sepsis, post-op of femoral artificial joint. 
7. Gender: female;        Age: 88ys;             Height: 165cm         
   Body Weight: 100kg            Heart weight: 327g.      
Diagnosis: advanced gastric cancer. 
8. Gender: female;        Age: 57ys;             Height: 160 cm         
   Body Weight: 88kg            Heart weight: 328 g.      
Diagnosis: pulmonary infection. 
9. Gender: male;        Age: 59ys;             Height: 174cm         
   Body Weight: 124 kg            Heart weight: 505 g.      
Diagnosis: trauma. 
10. Gender: female;        Age: 65ys;             Height: 162cm         
   Body Weight: 63 kg            Heart weight: 447g.      
Diagnosis: post-op CABG. 
11. Gender: female;        Age: 87ys;             Height: 172 cm         
   Body Weight: 95 kg            Heart weight: 574 g.      
Diagnosis: death of age. 
12. Gender: female;        Age: 82ys;             Height: 166cm         
   Body Weight: 67kg            Heart weight: 540g.      
Diagnosis: advanced lung cancer. 
13. Gender: male;        Age: 26ys;             Height: 172cm         
   Body Weight: 57 kg            Heart weight: 370g.      
Diagnosis: systematic fibrous pneumonia. 
14. Gender: female;        Age: 84ys;             Height: 170cm         
   Body Weight: 89kg            Heart weight: 511g.      
Diagnosis: cerebral embolism. 
15. Gender: male;        Age: 84ys;             Height: 178 cm         
   Body Weight: 93kg            Heart weight: 520 g.      
Diagnosis: pulmonary infection. 
16. Gender: male;        Age: 69ys;             Height: 176cm         
   Body Weight: 100 kg            Heart weight: 710g.      
Diagnosis: chronic pneumonia. 
17. Gender: male;        Age: 74ys;             Height: 178 cm         
   Body Weight: 89kg            Heart weight: 478 g.      
Diagnosis: death for ageing. 
18. Gender: male;        Age: 67ys;             Height: 165 cm         
   Body Weight: 89kg            Heart weight: 375g.      
Diagnosis: unknown. 
19. Gender: female;        Age: 76ys;             Height: 164 cm         
   Body Weight: 85kg            Heart weight: 430 g.      
Diagnosis: chronic multiple organs disease. 
20. Gender: female;        Age: 71ys;             Height: 167 cm         
   Body Weight: 80 kg            Heart weight: 423g.      
Diagnosis: coronary heart disease. 
21. Gender: male;        Age: 73ys;             Height: 180cm         
   Body Weight: 110 kg            Heart weight: 1010 g.      
Diagnosis: primary hypertension, diabetics, left ventricle embolism. 
22. Gender: male;        Age: 77ys;             Height: 178cm         
   Body Weight: 98kg            Heart weight: 478 g.      
Diagnosis: myocardial infarction.  
23. Gender: male;        Age: 75ys;             Height: 172cm         
   Body Weight: 75 kg            Heart weight: 411g.      
Diagnosis: diabetics, hypertension. 
24. Gender: female;        Age: 64ys;             Height: 163 cm         
   Body Weight: 65 kg            Heart weight: 402 g.      
Diagnosis: advanced breast cancer. 
25. Gender: female;        Age: 72ys;             Height: 161 cm         
   Body Weight: 75 kg            Heart weight: 478 g.      
Diagnosis: chronic hepatic failure, post-op pancreatic surgery. 
26. Gender: female;        Age: 75ys;             Height: 122 cm         
   Body Weight: 78 kg            Heart weight: 495g.      
Diagnosis: myocardial infarction. 
27. Gender: female;        Age: 76ys;             Height: 166 cm         
   Body Weight: 78 kg            Heart weight: 510g.      
Diagnosis: post-op of CABG. 
28. Gender: male;        Age: 59ys;             Height: 174cm         
   Body Weight: 65 kg            Heart weight: 386g.      
Diagnosis: pulmonary infective embolism. 
29. Gender: male;        Age: 67ys;             Height: 187cm         
   Body Weight: 83 kg            Heart weight: 415 g.      
Diagnosis: arrhythmia, myocardial infarction? 
30. Gender: male;        Age: 71ys;             Height: 175cm         
   Body Weight: 72kg            Heart weight: 452g.      
Diagnosis: myocardial infarction. 
31. Gender:  female;        Age: 70ys;             Height: 153cm         
   Body Weight: 60 kg            Heart weight: 410g.      
Diagnosis: coronary heart disease, post-op of CABG. 
32. Gender: female;        Age: 77ys;             Height: 170 cm         
   Body Weight: 82 kg            Heart weight: 389 g.      
Diagnosis: thoracic and abdominal aneurysm. 
33. Gender: female;        Age: 85ys;             Height: 159cm         
   Body Weight: 82 kg            Heart weight: 432g.      
Diagnosis: arrhythmia, post-implantation of pacemaker. 
34. Gender: male;        Age: 65ys;             Height: 174cm         
   Body Weight: 75 kg            Heart weight: 463 g.      
Diagnosis: advanced cancer. 
35. Gender: male;        Age: 57ys;             Height: 173cm         
   Body Weight: 80kg            Heart weight: 523 g.      
Diagnosis: chronic pulmonary infection. 
36. Gender: female;        Age: 65ys;             Height: 168 cm         
   Body Weight: 86kg            Heart weight: 342g.      
Diagnosis: chronic renal failure. 
37. Gender: male;        Age: 63ys;             Height: 174 cm         
   Body Weight: 64kg            Heart weight: 412g.      
Diagnosis: advanced lung cancer, multiple organs metastasis. 
38. Gender: female;        Age: 43ys;             Height: 170cm         
   Body Weight: 94 kg            Heart weight: 264 g.      
Diagnosis: left pulmonary embolism. 
39. Gender: female;        Age: 96ys;             Height: 160cm         
   Body Weight: 46kg            Heart weight: 342g.      
Diagnosis: abdominal aneurysm, myocardial infarction. 
40. Gender: male;        Age: 81ys;             Height: 175cm         
   Body Weight: 86kg            Heart weight: 510g.      
Diagnosis: chronic colitis, arrhythmia, implantation of pacemaker. 
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